Effectiveness of prehabilitation during neoadjuvant therapy for patients with esophageal or gastroesophageal junction cancer: a systematic review

Tomohiro Ikeda,Shusuke Toyama,Tsuyoshi Harada,Kazuhiro Noma,Masanori Hamada,Takashi Kitagawa
DOI: https://doi.org/10.1007/s10388-024-01049-9
2024-02-29
Esophagus
Abstract:Progression of the physical weakness during neoadjuvant therapy (NAT) in patients with esophageal or gastroesophageal junction cancer is a serious problem; however, prehabilitation during NAT has the potential to overcome the unmet need. Nevertheless, systematic reviews on this topic have not been summarized. Therefore, this systematic review aimed to determine prehabilitation's effectiveness, acceptability, and safety during NAT for patients with esophageal or gastroesophageal junction cancer. An electronic search was performed in the MEDLINE, Web of Science, CENTRAL, CINAHL, and PEDro databases. A meta-analysis was conducted to assess the effectiveness of prehabilitation during NAT, along with a descriptive analysis of acceptance and safety. This study analyzed data from three randomized controlled trials (RCTs) and nine non-RCTs involving 664 patients. The meta-analysis of two RCTs demonstrated that prehabilitation during NAT may be more effective than usual care in enhancing tolerance to NAT and grip strength; moreover, one RCT and three non-RCTs revealed that prehabilitation may reduce the risk of postoperative complications. The adherence rates for exercise programs in two RCTs and seven non-RCTs were 55–76%. Additionally, two studies reported a 76% adherence rate for multimodal prehabilitation programs, including exercise, dietary, and psychological care. Six studies reported no serious prehabilitation-related adverse events during NAT. Prehabilitation during NAT may be a safe and beneficial intervention strategy for patients with esophageal or gastroesophageal junction cancer. However, the investigation of strategies to enhance adherence is essential. Furthermore, additional high-quality RCTs are needed to examine the effect of prehabilitation during NAT.
gastroenterology & hepatology
What problem does this paper attempt to address?
The paper attempts to address the effectiveness, acceptability, and safety of prehabilitation training for patients with esophageal cancer or gastroesophageal junction cancer during neoadjuvant therapy (NAT). Specifically, the paper aims to evaluate through a systematic review whether prehabilitation training can improve these patients' tolerance to neoadjuvant therapy, grip strength, and reduce the risk of postoperative complications, as well as explore its feasibility and safety in practical application. Additionally, the study focuses on how to improve patient adherence to prehabilitation programs and the need for further high-quality randomized controlled trials to verify the effects of prehabilitation training.